chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Chills, Nausea, Pyrexia
Clinical narrative: Back ache; Severe nausea; Low grade fever (100); Chills; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 13Apr2021 at 09:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa drugs). Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 15:00, the patient experienced severe nausea, low grade fever (100), chills, soreness at injection site, and back ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 13Apr2021 at 15:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100 (units unspecified). The clinical outcome of the events severe nausea, low grade fever (100), chills, soreness at injection site, and back ache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Back ache; Severe nausea; Low grade fever (100); Chills; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 13Apr2021 at 09:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa drugs). Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 15:00, the patient experienced severe nausea, low grade fever (100), chills, soreness at injection site, and back ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 13Apr2021 at 15:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100 (units unspecified). The clinical outcome of the events severe nausea, low grade fever (100), chills, soreness at injection site, and back ache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle tightness, Neck pain, Pain in extremity, Tinnitus
Clinical narrative: Loud ringing in ears; Mild sore arm; Neck tightness and ache on the left side connected to my arm.; Neck tightness and ache on the left side connected to my arm.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 05Apr2021 at 09:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included heartburn, high cholesterol and sulfonamide allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced loud ringing in ears, had not gone away. Noticed the first night and when the patient woke up the next day. It had been a week and they ring high pitch noise all day and night. Other non-concerning effects were mild sore arm and neck tightness and ache on the left side connected to the arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event loud ringing in ears, mild sore arm, neck tightness and ache on left side connected to the arm were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Insomnia
Clinical narrative: Sensation of heat; after going to bed tossing and turning finally fell asleep; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8729), via an unspecified route of administration in the left arm on 07Apr2021 at 19:30 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6107), via an unspecified route of administration in the left arm on 16Mar2021 at 18:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 17:00, 24 hours after dose the patient experienced whole body felt like it was on fire but didn't have a fever, after going to bed tossing and turning finally fell asleep, woke up around 01:00 am and felt fine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the event whole body felt like it was on fire but didn't have a fever, after going to bed tossing and turning finally fell asleep was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Headache; Soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 16:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021, the patient experienced headache and soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache and soreness was resolved on an unknown date in Apr2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Vomiting
Clinical narrative: nausea; vomiting; fatigue; headache; body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 10Mar2021 at 23:00, the patient experienced nausea, vomiting, fatigue, headache and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, vomiting, fatigue, headache and body aches was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 66-year-old (non-pregnant) female patient received the first dose of BNT162b2 BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot#EP7534), at the age of 66, via an unspecified route of administration, left arm on Mar 17, 2021, at 19:45, single dose, for COVID-19 immunisation. Medical history included Factor V Leiden carrier and sulfonamide allergy. Concomitant medications included warfarin, diphenhydramine, calcium, Vitamin B and Vitamin C (ascorbic acid), for an unknown indication; from an unknown date. The patient previously took pseudoephedrine on unknown date, for unspecified indication; and experienced drug allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 18, 2021, at 02:00, patient experienced headaches, body aches and slight fever. The event lasted about 24 hours. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. The clinical outcome of the headaches, body aches and slight fever recovered on Mar 19, 2021. No follow-up attempts needed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Diarrhoea, Fatigue
Clinical narrative: Fever; Aches; Joint pain; Headache; Nausea; Chills; Injection site pain up to shoulder; Weakness; Tired; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 17:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, GERD (gastroesophageal reflux disease), HBP (high blood pressure), penicillin allergy and COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and pantoprazole sodium sesquihydrate (PANTOPRAZ); all taken from an unknow date for unknown indications. The patient previously took meloxicam and experienced a drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 09Apr2021 at 12:30, the patient experienced fever, aches, joint pain, headache, nausea, chills, injection site pain up to shoulder, weakness, tired and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, aches, joint pain, nausea, injection site pain up to shoulder, weakness, tired, diarrhea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fever; Aches; Joint pain; Headache; Nausea; Chills; Injection site pain up to shoulder; Weakness; Tired; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 17:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, GERD (gastroesophageal reflux disease), HBP (high blood pressure), penicillin allergy and COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and pantoprazole sodium sesquihydrate (PANTOPRAZ); all taken from an unknow date for unknown indications. The patient previously took meloxicam and experienced a drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 09Apr2021 at 12:30, the patient experienced fever, aches, joint pain, headache, nausea, chills, injection site pain up to shoulder, weakness, tired and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, aches, joint pain, nausea, injection site pain up to shoulder, weakness, tired, diarrhea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain
Clinical narrative: feeling unwell; fatigued; a little achy; This is a spontaneous report from a contactable consumer. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any known allergies.. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 13Apr2021 the patient was "generally feeling unwell the day after the shot, fatigued and a little achy". The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events feeling unwell, fatigued and a little achy were not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Ventricular extrasystoles
Clinical narrative: Pvcs exasperated post injection. Have them occasionally but post vaccine much more in quantity. Significantly more.; Also back and joint pain after bothbinjections; Also back and joint pain after bothbinjections; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included non-alcoholic steatohepatitis (nash), type 2 diabetes mellitus, and premature ventricular contractions. The patient previously had sulfa and experienced sulfonamide allergy. Concomitant medications taken within two weeks prior to vaccination included losartan potassium (LOSARTIN), valaciclovir hydrochloride (VALTREX), omeprazole (MANUFACTURER UNKNOWN), vitamin b complex (B-COMPLEX), krill oil (KRILLA) and vitamin d nos (VITAMIN D) (reported as d), all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patients premature ventricular contractions (Pvcs) exasperated post injection. The patient has had them occasionally but post vaccine much more in quantity. Significantly more. On 08Apr2021, the patient also experienced back and joint pain after both injections. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events premature ventricular contractions (Pvcs) exasperated post injection, also back and joint pain after both injections was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dysstasia, Headache, Loss of personal independence in daily activities, Pain
Clinical narrative: Body aches all over; Not able to stand up straight or do anything; Fever of 103 for almost 2 days; Horrible headache that would not go away with anything; Lost 2 days of work.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 11Apr2021 at 09:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 21Mar2021 at 09:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 02:00, the patient experienced fever of 103 (units not specified) for almost two days, horrible headache that would not go away with anything, body aches all over and the patient was not able to stand up straight or do anything. The patient lost two days of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 103 for almost two days, horrible headache, body aches all over, not able to stand up straight or do anything and lost two days of work was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches all over; Not able to stand up straight or do anything; Fever of 103 for almost 2 days; Horrible headache that would not go away with anything; Lost 2 days of work.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 11Apr2021 at 09:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 21Mar2021 at 09:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 02:00, the patient experienced fever of 103 (units not specified) for almost two days, horrible headache that would not go away with anything, body aches all over and the patient was not able to stand up straight or do anything. The patient lost two days of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 103 for almost two days, horrible headache, body aches all over, not able to stand up straight or do anything and lost two days of work was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain, Tinnitus
Clinical narrative: severe body pain; ears ringing; faint feeling; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient previously received amoxicilline and morphine for unknown indication on an unknown date and experienced drug allergy. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 21:00 the patient experienced severe body pain, ears ringing and faint feeling. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe body pain, ears ringing and faint feeling were not resolved at the time of the report.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable healthcare professional. A 51-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN5318) via intramuscular route of administration in the right arm on 02Feb2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) on an unknown date for unknown indication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3248) via intramuscular route of administration in the right arm on 07Jan2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2020, the patient experienced tinnitus. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. On 02Apr2021, the patient underwent lab test and procedure which included COVID-19 test and the result was found to be negative. The clinical outcome of the event tinnitus was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Large red itchy rash appeared at the injection site; large red itchy rash appeared at the injection site; Red rash wrapped around to the inside of arm; Itchy rash wrapped around to the inside of arm; large red itchy rash appeared at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0153) via an unspecified route of administration in the arm left on 05Apr2021 at 12:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 13Mar2021 at 11:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 12:30 within 24 hours of vaccination, the patient experienced large red itchy rash at the injection site and wrapped around to the inside of arm. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and  emergency room or department or urgent care. The clinical outcome of the events large red itchy rash at the injection site and wrapped around to the inside of arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Pain in extremity
Clinical narrative: Dizziness and nausea felt like vomiting (But did not) within first 10 minutes of receiving vaccine.Headache and left arm pain came later on.; Dizziness and nausea felt like vomiting (But did not) within first 10 minutes of receiving vaccine.Headache and left arm pain came later on.; Dizziness and nausea felt like vomiting (But did not) within first 10 minutes of receiving vaccine.Headache and left arm pain came later on.; Dizziness and nausea felt like vomiting (But did not) within first 10 minutes of receiving vaccine.Headache and left arm pain came later on.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PFIZEREW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 09:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as not available. The patient had no known allergies to food, medicine or other products. Concomitant medications taken within two weeks prior to vaccination included loratadine (MANUFACTURER UNKNOWN), fluticasone propionate (FLONASE) and paracetamol (ACETAMINOPHEN), all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced dizziness and nausea felt like vomiting (but did not) within first 10 minutes of receiving vaccine on 06Apr2021 at 09:55. Headache and left arm pain came later on, on 06Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events dizziness and nausea felt like vomiting (But did not) within first 10 minutes of receiving vaccine, headache and left arm pain came later on was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: Felling itchy and odd pins needles sensation throughout body. No rash; Felling itchy and odd pins needles sensation throughout body. No rash; This is a spontaneous report received from a contactable other healthcare professional (patient).   A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 11:30 (at the age of 56-years-old) as a single dose for COVID-19 immunization. Medical history included pituitary tumour and penicillin allergy from unspecified dates. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications taken within two weeks of vaccination included cabergoline (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL), both from unknown dates taken for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:15, the patient experienced felling itchy and odd pins needles sensation throughout body. No rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of felling itchy and odd pins needles sensation throughout body, no rash was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Paraesthesia
Clinical narrative: Felling itchy and odd pins needles sensation throughout body. No rash; Felling itchy and odd pins needles sensation throughout body. No rash; This is a spontaneous report received from a contactable other healthcare professional (patient).   A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 11:30 (at the age of 56-years-old) as a single dose for COVID-19 immunization. Medical history included pituitary tumour and penicillin allergy from unspecified dates. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications taken within two weeks of vaccination included cabergoline (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL), both from unknown dates taken for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:15, the patient experienced felling itchy and odd pins needles sensation throughout body. No rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of felling itchy and odd pins needles sensation throughout body, no rash was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus worse since vaccine; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on an unknown date Apr2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included High BP (blood pressure high). Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), rosuvastatin (ROSUVASTATINE) and multivitamin (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 22Mar2021 at 12:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, the patient experienced tinnitus worse since vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of tinnitus was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Gait disturbance, Joint stiffness
Clinical narrative: Face gets red and hot on right side every night. I had ankle surgery in March and it's still healing but now my joint has become very stiff and it hurts to walk.; Face gets red and hot on right side every night. I had ankle surgery in March and its still healing but now my joint has become very stiff and it hurts to walk.; Face gets red and hot on right side every night. I had ankle surgery in March and its still healing but now my joint has become very stiff and it hurts to walk.; Face gets red and hot on right side every night. I had ankle surgery in March and its still healing but now my joint has become very stiff and it hurts to walk.; This is a spontaneous report from a contactable healthcare professional, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 12:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included joint surgery (right ankle surgery), attention deficit-hyperactivity disorder (ADHD) and anxiety. The patient did not have any known allergies to food, medications or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), gabapentin (MANUFACTURER UNKNOWN), vitamin b nos (B-COMPLEX) and multivitamin (MANUFACTURER UNKNOWN); all for unknown indication and start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021 at 21:00, the patient experienced face got red and hot on right side every night. She had ankle surgery in March and it was still healing but then her joint had become very stiff and it hurts to walk. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events face got red, hot on right side, joint had become very stiff and hurts to walk were not recovered at the time of this report.  No follow up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Eye discharge, Eye pain, Fatigue, Flushing
Clinical narrative: Immediately bad  headache with eyes hurting; dry felt like they were glued; dry felt like they were glued; flushing of face and neck; Eyes felt really puffy; itching of neck and arms; extremely fatigued; Immediately bad  headache with eyes hurting; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic allergic rhinitis, eustachian tube dysfunction, autoimmune thyroiditis, allergies to some medications, additives, preservatives, chemical, food and environmental allergies since an unspecified date. Concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 15:00, the patient experienced immediately bad headache with eyes hurting, dry felt like they were glued, flushing of face and neck, itching of neck and arms, eyes felt really puffy and sore immediately. Lasted for almost three days. The patient was extremely fatigued and was asleep within two hours and did not wake up till next morning. Headache and eyes hurting lasted long. Therapeutic measures were not taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events immediately bad headache with eyes hurting, dry felt like they were glued, flushing of face and neck, eyes felt really puffy, itching of neck and arms and extremely fatigued was resolved on 03Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Periorbital swelling, Pruritus
Clinical narrative: Immediately bad  headache with eyes hurting; dry felt like they were glued; dry felt like they were glued; flushing of face and neck; Eyes felt really puffy; itching of neck and arms; extremely fatigued; Immediately bad  headache with eyes hurting; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic allergic rhinitis, eustachian tube dysfunction, autoimmune thyroiditis, allergies to some medications, additives, preservatives, chemical, food and environmental allergies since an unspecified date. Concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 15:00, the patient experienced immediately bad headache with eyes hurting, dry felt like they were glued, flushing of face and neck, itching of neck and arms, eyes felt really puffy and sore immediately. Lasted for almost three days. The patient was extremely fatigued and was asleep within two hours and did not wake up till next morning. Headache and eyes hurting lasted long. Therapeutic measures were not taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events immediately bad headache with eyes hurting, dry felt like they were glued, flushing of face and neck, eyes felt really puffy, itching of neck and arms and extremely fatigued was resolved on 03Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Left foot has been numb ever since got home from vaccine. Can bend toes, walk, and move on foot, but the whole top is numb to touch.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732, Expiration date: an unknown date in Jul2021) via an unspecified route of administration in the left arm on 11Apr2021 at 15:00(at the age of 21-years-old) as a single dose for COVID-19 immunisation. The medical history included sulphonamide allergy. Concomitant medications included clindamycin (CLINDAMICINA) and benzyl peroxide (MANUFACTURER UNKNOWN) started on unknown dates and for unspecified indications. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and augmentin (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, reportedly the patient's left foot has been numb ever since got home from vaccine. She can bend toes, walk, and move on foot, but the whole top was numb to touch. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event left foot has been numb ever since got home from vaccine. she can bend toes, walk, and move on foot, but the whole top is numb to touch was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Rash
Clinical narrative: Rash, bumps; Pain in the area between the adbomen and hip joint; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 08Apr2021 at 14:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included myasentia Gravis, complex regional pain syndrome  (CRPS), sinus issues and penicillin allergy. Concomitant medications included mycophenolate mofetil (CELLCEPT), pyridostigmine (MANUFACTURER UNKNOWN), celecoxib (CELEBREX) and vitamin supplement; all for unknown indication from an unknown date and unknown if ongoing. The patient previously received alendronate sodium (FOSAMAX) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:30, within 24 hours, the patient got rash, bumps and pain in the area between the abdomen and hip joint. The events resulted in a visit to the doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with hydrocortisone cream. The clinical outcome of the events rash, bumps and pain in the area between the abdomen and hip joint were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: full body muscle pain and soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Unknown) via an unspecified route of administration in the right arm on 09Apr2021 at 10:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced full body muscle pain and soreness. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event full body muscle pain and soreness was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.